sxc catamaran

Staying current is easy with Crain’s news delivered straight to your inbox.

Free of charge.

Sxc to rebrand as catamaran corp..

(Crain's) — SXC Health Solutions Corp. will rebrand itself as Catamaran Corp., now that it has completed a $4.4 billion deal to acquire Rockville, Md.-based competitor Catalyst Health Solutions Inc.

The Lisle-based company's new name was revealed in a research note published Tuesday by analyst Amanda Murphy of Chicago-based investment firm William Blair & Co.

SXC in the last six weeks has filed to trademark “Catamaran,” “C Catamaran” and “C Catamaran Stay Well Ahead,” according to records of the U.S. Patent and Trademark Office.

An SXC spokeswoman would not confirm the name change Tuesday morning.

After the close of trading on Monday, SXC announced that the Catalyst deal had closed, creating the fourth-largest pharmacy benefits manager in the country by prescription volume, with combined annual revenue of $13 billion.

The company also said it was appointing two new directors to its board, including Harry Kraemer Jr., former CEO of Deerfield-based Baxter International Inc.

The combined company is expected to process more than 200 million prescriptions in 2012 and has said it hopes to reap $125 million in synergies from the merger, 80 percent of which will be realized by the end of 2014.

“We believe the Catalyst transaction represents a meaningful positive for the combined company's ability to compete going forward (both from a purchasing power/scale standpoint and ability to win future business in the 2014 selling season and beyond),” Ms. Murphy wrote in the research note.

Mr. Kraemer Jr. is an executive partner at Chicago-based private-equity firm Madison Dearborn Partners LLC and a board member of Evanston-based NorthShore University HealthSystem.

In addition to Mr. Kraemer, Steven Epstein, a Catalyst director since 2003, has joined the Catamaran board. A health care attorney, Mr. Epstein is a founder of Epstein Becker & Green P.C., a Washington law firm. He is on the board of several for-profit companies and serves as chairman of the Columbia University Law School Board of Visitors.

Curtis Thorne and Philip Reddon have resigned from the SXC board, the company said.

“The combination of SXC and Catalyst merges two highly successful, fast-growing enterprises to deliver the resources, skill and scale to solve the health care cost challenge,” CEO Mark Thierer said in a news release. “Together, we are able to chart a new course to deliver distinct advantages to all stakeholders.”

Mr. Thierer noted at an investor conference last month that the name change was afoot. He said at the time that the change was part of a shift in strategy in which the combined company would compete directly with the PBM industry's biggest players, Express Scripts Holding Co. and CVS Caremark Corp., for contracts with Fortune 500 employers.

Catalyst stockholders received $28 per share and 0.6606 of an SXC common share for each Catalyst share they own.

More in Health Care

Swedish pharma brings on Horizon execs to launch U.S. HQ in Chicago

Daniel Camardo and Joe Whalen will lead business development efforts here for rare disease drug maker Immedica Pharma.

As Walgreens spirals downward, so does Stefano Pessina's fortune

Following an expensive and failed health care pivot orchestrated by the executive chairman, Walgreens' stock has hit lows not seen since the 1990s. His portfolio is paying dearly for it.

Expectant mothers on Medicaid get fewer ultrasounds, warnings for birth defects

The disparity between patients with public and private insurance may play into further disparity regarding prenatal diagnoses of the most common birth defect in the U.S., according to a new study from Lurie and Advocate.

Most Popular

Get our newsletters

Staying current is easy with Crain's news delivered straight to your inbox, free of charge.

Subscribe today

With a Crain’s Chicago Subscription you get exclusive access, insights and experiences to help you succeed in business.

• Today's news
• Reviews and deals
• Climate change
• 2024 election
• Newsletters
• Fall allergies
• Health news
• Mental health
• Sexual health
• Family health
• So mini ways
• Unapologetically
• Buying guides

Entertainment

• How to Watch
• My watchlist
• Stock market
• Biden economy
• Personal finance
• Stocks: most active
• Stocks: gainers
• Stocks: losers
• Trending tickers
• World indices
• US Treasury bonds
• Top mutual funds
• Highest open interest
• Highest implied volatility
• Currency converter
• Basic materials
• Communication services
• Consumer cyclical
• Consumer defensive
• Financial services
• Industrials
• Real estate
• Mutual funds
• Credit cards
• Balance transfer cards
• Cash back cards
• Rewards cards
• Travel cards
• Online checking
• High-yield savings
• Money market
• Home equity loan
• Personal loans
• Student loans
• Options pit
• Fantasy football
• Pro Pick 'Em
• College Pick 'Em
• Fantasy baseball
• Fantasy hockey
• Fantasy basketball
• Download the app
• Daily fantasy
• Scores and schedules
• GameChannel
• World Baseball Classic
• Premier League
• CONCACAF League
• Champions League
• Motorsports
• Horse racing

New on Yahoo

• Privacy Dashboard

UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billion

By Sneha Banerjee (Reuters) - Health insurer UnitedHealth Group Inc agreed to buy Catamaran Corp in a deal worth about $12.8 billion (8.65 billion pounds) to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co . Pharmacy benefit managers (PBM) administer drug benefits for employers and health plans and run large mail order pharmacies, helping them get better prices from drugmakers. As employers look to cut prescription costs on expensive drugs, the deal with Catamaran will give UnitedHealth's pharmacy benefits unit, OptumRx, the scale to negotiate favourable prices from pharmacy companies. U.S. drug prices rose 12 percent in 2014 due to a new treatment for hepatitis C that cost more than $80,000 but cured almost all recipients with few side effects. Another new class of drugs, to treat high cholesterol, is expected to hit the market in 2015 and has insurers worried about drug costs this year as well. The purchase of Catamaran will increase UnitedHealth's market share to 15 percent to 20 percent of the people who receive their drug benefits through pharmacy benefit managers, BMO Capital Markets analyst Jennifer Lynch said in a research note. With a combined 1 billion scripts annually, UnitedHealth will be about the same size as current industry number two, CVS Health Corp , she added. Catamaran was formed after SXC Health Solutions and PBM Catalyst Health Solutions merged in 2012. UnitedHealth's offer of $61.50 per share represents a premium of 27 percent to Catamaran's Friday close on the Nasdaq. Catamaran's stock was trading at $60.01 premarket on Monday, while UnitedHealth was up nearly 4 percent. The deal "makes sense to us, but admittedly came much earlier than we expected," Jefferies analyst Brian Tanquilut said in a research note. "We had always viewed Catamaran as a compelling asset for companies looking for scale in the PBM sector such as Optum or Walgreens but expected Catamaran to grow the business much further before pursuing a sale." He added that the offer seemed adequate and he did not expect competing bids at this point. The deal value is based on Illinois-based Catamaran's total diluted shares outstanding as of Dec. 31. The transaction is expected to close in the fourth quarter of 2015 and add about 30 cents per share to UnitedHealth's profit in 2016, the companies said. Catamaran Chief Executive Officer Mark Thierer will be CEO of OptumRx and OptumRx CEO Timothy Wicks will become president. (Additional reporting by Caroline Humer in New York; Editing by Savio D'Souza, Saumyadeb Chakrabarty and Meredith Mazzilli)

Recommended Stories

Lakers coach jj redick reveals team's starting lineup before training camp.

No, the Lakers aren't starting Bronny.

Yahoo Top 10: Tennessee's road win at Oklahoma boosts Vols to No. 1 while USC falls out of rankings

This college football season is still devoid of major upsets, but some teams have played tougher schedules than others.

Caitlin Clark, DiJonai Carrington shut down idea that Game 1 eye poke was intentional: ‘Just watch the play’

“I don’t even know why I would intend to hit anybody in the eye.”

College Football Playoff Picture: Here's what the 12-team bracket looks like after Week 4

Boise State moves into the 12-team field after Northern Illinois lost in Week 4.

Panic Meter: Anthony Richardson, Miami Dolphins, all the TEs + Waiver Wire pickups | Yahoo Fantasy Forecast

Week 3 is in the books and oh my there's a lot of panic on these fantasy streets. Dalton Del Don joins Scott Pianowski for another edition of the 'People's Panic Meter' to answer all of your listener submissions. The duo examines the situations for Anthony Richardson, Brandon Aiyuk and the entire TE position.

The Mandela effect: 10 examples that explain what it is and why it happens

No, Mr. Monopoly didn't have a monocle — it's just one example of a false memory that many of us share, an expert says.

Ryan Pepiot throws fourth immaculate inning in Rays history

With only 117 in MLB history, an immaculate inning is rarer than a no-hitter.

Bottled water contains harmful contaminants, experts warn. Here are safer ways to hydrate.

Experts say that the potential health — and environmental — risks of bottled water outweigh the benefits for people where tap water is safe.

Padres turn game-ending triple play, clinch playoff berth in win over Dodgers

The ninth inning was shaping up to be a gut punch for San Diego. Instead, it's L.A. who was left stunned.

AP Top 25: Tennessee moves to No. 5, Missouri drops out of top 10

The Volunteers won on the road at Oklahoma on Saturday.

‘Mercury’ Morris, legendary Dolphins running back, dies at age 77

Morris, a two-time Super Bowl winner and three-time Pro Bowler, was a key part of Miami's 1972 unbeaten season.

Disney's theme parks have seen a slowdown. Is it a temporary blip?

Disney's parks business is slowing. But that might not be as concerning as it seems.

Conference realignment strikes again & Week 5 preview | College Football Enquirer

Oh boy, another conference realignment update! Dan Wetzel, Ross Dellenger and SI's Pat Forde react to the latest news in conference realignment. They dive into the Pac-12 securing a commitment from Utah State, the AAC fighting to keep its top teams, and the Mountain West scrambling to stay alive.

See the iPhone 16’s game-changing battery removal process in new iFixit teardown

A teardown by iFixit now shows the new battery removal process in action, and it looks easier than ever.

Geopolitics emerges as Jamie Dimon's chief concern for economy: It's 'getting worse'

JPMorgan Chase CEO Jamie Dimon once again cited global instability as a reason why inflation may not yet be under control, saying that geopolitics is "getting worse."

Ranking the NBA's No. 2 options: Lakers, Celtics boast the league's best co-stars

Within all 30 teams is a hierarchy. Here's a look at each franchise's second go-to player.

This knit jacket is better than J.Crew's coatigan, fans say — it's over 50% off

Why wait for chilly weather? This polished bestseller, just $34, will keep you toasty even if the A/C is still blasting.

St. Louis Cardinals 2024 offseason preview: What's next for Paul Goldschmidt, Nolan Arenado and Co.?

The 2024 Cardinals were average in run prevention and below average in run production.

Alex Morgan bids emotional farewell in final game of her soccer career

Joined by her daughter Charlie, Morgan said goodbye to the San Diego Wave and her career as a soccer player Sunday night.

The potential investor upside of a Google breakup — if John Rockefeller is any guide

Google's legal troubles could force it to sell off some of its prized businesses, but investors worried about that outcome may find some comfort in what happened to John Rockefeller’s Standard Oil more than a century ago.

SXC Health Solutions Unveils a New Name Following Merger: Catamaran

New Stock Ticker Symbol and Leadership Team Announced

LISLE, IL , July 10, 2012 /PRNewswire/ - Following the recent completion of its merger with Catalyst Health Solutions, Inc., SXC Health Solutions Corp. today unveiled a new name and brand for the company, as well as formally announced its leadership team. The new name, Catamaran, reflects the union of two of the industry’s fastest-growing pharmacy benefits management companies (PBM) to create the fourth largest PBM in the U.S. by prescription volume.

Beginning tomorrow, the company’s shares will be traded under the ticker CTRX on the NASDAQ and as CCT on the Toronto Stock Exchange.

The company selected the name Catamaran to reflect its nimble, flexible approach to helping clients navigate today’s turbulent healthcare environment to contain costs and enhance the well-being of its members. Catamaran’s clients include the broadest, most diverse base of any PBM, comprising large employers, health plans, government entities, unions, workers’ compensation, TPAs, long term care, hospice and PBMs.

“Catamaran is the most viable alternative for organizations who are struggling to solve the healthcare cost challenge, and we’re eager to put our enhanced resources to work for them,” said Mark Thierer , Chairman and CEO of Catamaran. “We have the skill and scale to deliver compelling financial results and the clinical intelligence to deliver sustainable improvements in the health of members.”

The new Catamaran has substantial resources to apply to the market’s challenges. The merged company will have estimated annual revenues of $13 billion , placing it among the top 250 companies in the U.S. and among the top 15 companies in the Chicagoland area, where it is headquartered. Catamaran will serve approximately 25 million members and will have an annual volume of more than 200 million adjusted pharmacy benefits management prescriptions.

Catamaran also formally announced its new leadership team, which leverages talents from both SXC and Catalyst. Mark Thierer will lead the firm as Chairman and CEO, and Jeff Park will serve as Executive Vice President and CFO. Former Catalyst President and Chief Operating Officer Rick Bates will serve as Executive Vice President, Market Segments. In addition, former Catalyst board member Steven B. Epstein will join the new Catamaran board. David Blair , former Chairman and CEO of Catalyst, has committed to provide ongoing support to the combined company to ensure a seamless and successful integration.

Catamaran is headquartered in Lisle, Illinois , with multiple locations in the United States and Canada .

About Catamar an Catamaran, the industry’s fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 200 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran’s skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada . For more information, please visit www.catamaranRx.com .

SOURCE SXC Health Solutions Corp.

Catamaran Corporation Unveils New Specialty Pharmacy Offering

Catamaran Corp, a leading provider of pharmacy benefit management (PBM) services and technology announced it has launched its new specialty brand, BriovaRx.

Catamaran Corp, a leading provider of pharmacy benefit management (PBM) services and technology announced it has launched its new specialty brand, BriovaRx. BriovaRx marks the beginning of a new day in the specialty sector, delivering personalized, holistic care to patients with complex and chronic conditions to improve health outcomes.

“Patients diagnosed with complex medical conditions often face insurmountable challenges in managing their conditions - financially, emotionally, and physically,” said Mark Thierer, chairman and chief executive officer of Catamaran. “In contrast to an industry that’s focused solely on the drug, BriovaRx focuses on the patient, ensuring they receive one-on-one support and a personalized plan that addresses all conditions — not just the underlying chronic illness – to help them lead healthy, vibrant lives.”

As the fifth largest specialty pharmacy in the nation, BriovaRx has the skill and scale to effectively manage costs for health plans and other payers challenged by escalating specialty drug prices and increased utilization. According to projected trend figures, specialty plan spending is estimated to grow from 18% of total pharmacy costs (2010) to 43% by 2020.

“Since 11 of the 16 most utilized drugs in the nation are classified as specialty, BriovaRx addresses a growing need in our communities to better manage complex conditions like hepatitis C, cancer, crohn’s Disease, HIV, multiple sclerosis, and others,” said Albert Thigpen, senior vice president, Pharmacy Operations, Catamaran. “BriovaRx provides a support system for the patient and coordinates the efforts of providers and payers to streamline delivery and administration of treatment to ensure a more positive experience for every patient and more time for physicians to focus on care.”

Catamaran, under its former name SXC Health Solutions, has more than 15 years of experience within specialty pharmacy. BriovaRx replaces its former specialty pharmacy offering, Medfusion/Ascend.

About Catamaran

Catamaran, the industry’s fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 200 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing 1 in every 5 prescription claims in the United States, Catamaran’s skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Illinois, with multiple locations in the United States and Canada. For more information, please visit www.catamaranRx.com .

CEEVs, Neurovascular Coupling, and Functional Connectivity Are Potential Markers For Mild Cognitive Impairment

Pharmacy Focus: World Psychedelics Day

Arimoclomol Becomes First FDA Approved Treatment for Neimann-Pick Disease Type C

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Transfusion-Related Acute Lung Injury Requires Prompt Recognition Due to Link With Intravenous Immunoglobulin

FDA Approves Benralizumab for Eosinophilic Granulomatosis With Polyangiitis

2 Commerce Drive Cranbury, NJ 08512

609-716-7777

English (USA)

English (UK)

English (Canada)

English (India)

Deutsch (Deutschland)

Deutsch (Österreich)

Deutsch (Schweiz)

Français (France)

Français (Suisse)

Nederlands (Nederland)

Nederlands (België)

• Top Capitalization
• United States
• North America
• Middle East
• Sector Research
• Earnings Calendar
• Equities Analysis
• Most popular
• AMD (ADVANCED MICRO DEVICES)
• NIPPON ACTIVE VALUE FUND PLC
• COMMERZBANK AG
• UNICREDIT S.P.A.
• VOLKSWAGEN AG
• META PLATFORMS, INC.
• THE EDINBURGH INVESTMENT TRUST PLC
• Index Analysis
• Indexes News
• EURO STOXX 50
• Currency Cross Rate
• Currency Converter
• Forex Analysis
• Currencies News
• Precious metals
• Agriculture
• Industrial Metals
• Livestock and Cattle
• CRUDE OIL (WTI)
• CRUDE OIL (BRENT)

• Yield Curve
• Developed Nations
• Emerging Countries
• South America
• Analyst Reco.
• Capital Markets Transactions
• New Contracts
• Profit Warnings
• Appointments
• Press Releases
• Security Transactions
• Earnings reports
• New markets
• New products
• Corporate strategies
• Legal risks
• Share buybacks
• Mergers and acquisitions
• Call Transcripts
• Currency / Forex
• Commodities
• Cryptocurrencies
• Interest Rates
• Asset Management
• Climate and ESG
• Cybersecurity
• Geopolitics
• Central Banks
• Private Equity
• Business Leaders
• All our articles
• Most Read News
• All Analysis
• Satirical Cartoon
• Today's Editorial
• Crypto Recap
• All our investments
• Asia, Pacific
• Virtual Portfolios
• USA Portfolio
• European Portfolio
• Asian Portfolio
• My previous session
• My most visited
• Growth stocks at reasonable prices
• Undervalued stocks
• Multibaggers
• Momentum stocks
• Dividend Kings
• The Vegan Market
• Artificial Intelligence
• Millennials
• Bionic engineering
• In Vino Veritas
• Unusual volumes
• New Historical Highs
• New Historical Lows
• Top Fundamentals
• Sales growth
• Earnings Growth
• Profitability
• Rankings Valuation
• Enterprise value
• Top Consensus
• Analyst Opinion
• Target price
• Estimates Revisions
• Top ranking ESG
• Environment
• Visibility Ranking
• Stock Screener Home
• Powerful brands
• The Golden Age of Video Games
• Pricing Power
• Oversold stocks
• Overbought stocks
• Close to resistance
• Close to support
• Accumulation Phases
• Most volatile stocks
• Top Investor Rating
• Top Trading Rating
• Top Dividends
• Low valuations
• All my stocks
• Stock Screener
• Stock Screener PRO
• Portfolio Creator
• Event Screener
• Dynamic Chart
• Economic Calendar
• Our subscriptions
• Our Stock Picks
• Thematic Investment Lists

Catamaran Corp Nasdaq

Ca78505p1009, managed healthcare.

SXC Health Solutions, Corp. : SXC Health Solutions Unveils a New Name Following Merger: Catamaran

New Stock Ticker Symbol and Leadership Team Announced

LISLE, IL, July 10, 2012 /PRNewswire/ - Following the recent completion of its merger with Catalyst Health Solutions, Inc., SXC Health Solutions Corp. today unveiled a new name and brand for the company, as well as formally announced its leadership team.  The new name, Catamaran, reflects the union of two of the industry's fastest-growing pharmacy benefits management companies (PBM) to create the fourth largest PBM in the U.S. by prescription volume.

Beginning tomorrow, the company's shares will be traded under the ticker CTRX on the NASDAQ and as CCT on the Toronto Stock Exchange.

The company selected the name Catamaran to reflect its nimble, flexible approach to helping clients navigate today's turbulent healthcare environment to contain costs and enhance the well-being of its members.   Catamaran's clients include the broadest, most diverse base of any PBM, comprising large employers, health plans, government entities, unions, workers' compensation, TPAs, long term care, hospice and PBMs.

"Catamaran is the most viable alternative for organizations who are struggling to solve the healthcare cost challenge, and we're eager to put our enhanced resources to work for them," said Mark Thierer, Chairman and CEO of Catamaran. "We have the skill and scale to deliver compelling financial results and the clinical intelligence to deliver sustainable improvements in the health of members."

The new Catamaran has substantial resources to apply to the market's challenges.   The merged company will have estimated annual revenues of $13 billion, placing it among the top 250 companies in the U.S. and among the top 15 companies in the Chicagoland area, where it is headquartered.  Catamaran will serve approximately 25 million members and will have an annual volume of more than 200 million adjusted pharmacy benefits management prescriptions.

Catamaran also formally announced its new leadership team, which leverages talents from both SXC and Catalyst.   Mark Thierer will lead the firm as Chairman and CEO, and Jeff Park will serve as Executive Vice President and CFO.   Former Catalyst President and Chief Operating Officer Rick Bates will serve as Executive Vice President, Market Segments.  In addition, former Catalyst board member Steven B. Epstein will join the new Catamaran board.   David Blair, former Chairman and CEO of Catalyst, has committed to provide ongoing support to the combined company to ensure a seamless and successful integration.

Catamaran is headquartered in Lisle, Illinois, with multiple locations in the United States and Canada.

About Catamaran Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs.  Managing more than 200 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit www.catamaranRx.com .

SOURCE SXC Health Solutions Corp.

Latest news about Catamaran Corp

Chart Catamaran Corp

Company Profile

• Stock Market
• News Catamaran Corp
• SXC Health Solutions, Corp. : SXC Health Solutions Unveils a New Name Following Merger

Business | Executive Profile: Mark Thierer, chairman and…

Share this:.

• Click to share on Facebook (Opens in new window)
• Click to share on X (Opens in new window)
• Click to print (Opens in new window)
• Click to email a link to a friend (Opens in new window)
• Top Workplaces
• Real Estate
• Transportation

Business | Executive Profile: Mark Thierer, chairman and CEO of Catamaran Corp.

“If you’re ever actually looking for them, you’d be amazed where you’d find them. Off-the-beaten-path bars, convenience stores, gas stations — the places you’d least expect,” he said.

Thierer is chairman and chief executive of one of the Chicago area’s fastest-growing companies, Lisle-based pharmacy benefit manager Catamaran Corp. The stickers play an integral — starring, actually — role in his hobby of crafting handmade greeting cards to send to friends, family and business associates to thank, congratulate, acknowledge or just because.

Each of the 300 or so cards he has sent is filled with wink-of-the-eye humor and personal touches, starting with an ornate envelope sealed with hot wax and embossed with a custom stamp branding it “Another Amazing Thierer Sticker Card.”

It’s a quirky habit for a 52-year-old suburban father of two, no less the CEO of a soon-to-be Fortune 250 company.

The whimsical, warm cards provide a stark contrast to the hard-charging, intense competitor. They also serve as a creative outlet for a numbers-driven man and serve as an indelible tool to make deeper connections with people, particularly in the business world.

One recipient was Harry Kraemer, former CEO of Baxter International, and now a professor at Northwestern University’s Kellogg School of Management and partner at the powerhouse private equity firm Madison Dearborn Partners.

Thierer surprised Kraemer with the card about a year ago after attending one of the professor’s leadership classes.

“You could tell he put a lot of time and effort into it, and it was very genuine,” Kraemer said. “It was a very unique thing to be doing for an executive, particularly in an age now where communication has been reduced to texts and emails.”

Kraemer keeps the card in his office, next to his phone. When Thierer invited Kraemer to join Catamaran’s board a few months ago, Kraemer said yes, without hesitation.

“There are very few people whose board I would join at this point, and Mark was one of them,” Kraemer said.

Thierer calls the sticker cards his calling card and signature. The way things are going, he’ll be sending a lot more of them. If he can find the time.

Thierer is on, as he describes it, a “once-in-a-lifetime ride.” More accurately, he’s the conductor.

Hard turn required

Since Thierer joined Catamaran, formerly known as SXC Health Solutions Inc., in 2006, he has led it to exponential growth. In 2006, the company logged $81 million in annual revenue. This year, it projects to do about $10 billion.

Its stock, once mired in the $10 range, trades for nearly $100 per share. The price has surged so much that the company plans a 2-for-1 split.

To get there required a hard turn.

When Thierer stepped in as president and chief operating officer, SXC was a small boutique technology firm that provided infrastructure to dozens of pharmacy benefit managers.

Also known as PBMs, these companies administer prescription drug benefit programs for health insurers, employers and other groups by negotiating with pharmaceutical firms and pharmacies to lower prices. They then pay pharmacies to dispense drugs.

SXC controlled a significant portion of that small but targeted market with a lucrative niche. But there was little room for growth.

Thierer saw something more.

“I saw a diamond in the rough,” he said. “They had the market-leading position by an order of magnitude, and I knew there was something special there.”

With more than 20 years of experience developing its tech systems and building market share, SXC had built a high barrier to entry against competitors in the tech field. And although its information technology business makes up a fraction of the company’s revenue, Thierer insists it remains its primary differentiator.

“The thought process became, how do you leverage this phenomenal core asset?” Thierer said. Another question was, aside from raising the price of its products, how can the company grow if it has a dominant position in the market?

The answer: Start buying its customers.

Because SXC ran the IT infrastructure of the PBMs, it knew the business model. And because the IT platform is such an integral part of the business, integration would be relatively seamless and inexpensive.

The first move came in February 2008. SXC bought National Medical Card Systems Inc. in a $148 million cash and stock deal. News of Thierer’s “big bet” sent shares down more than 13 percent in a two-day period.

National Medical covered 2.3 million customers with a full suite of PBM services, including the management of drug benefits, and an established mail-order and specialty pharmaceutical business. The acquisition doubled SXC’s employees and transformed it overnight from a small tech company to a full-service PBM.

“It was a really big, strategic bet. It was very aggressive, and not everyone agreed with it at the time. We were not a service company. We did not have those kinds of skills,” Thierer said.

Jeff Park, Catamaran’s chief financial officer, said he felt like he and Thierer were betting their careers on the deal.

“This was something that was either going to be a crowning achievement, or candidly, my last job,” Park said. “We made the decision that there was only one way for this to go, and we were going to succeed and we were going to make sure this is going to work. We were all in.”

Parents an influence

Thierer was introduced early to the idea of taking a calculated risk — and watching it pay off.

Mark Alan Thierer was born in 1960 on a 320-acre farm near the small town of Traer in east-central Iowa. His father planted corn and soybeans and raised hogs. But his parents had greater ambitions.

When Mark was 8, the family uprooted for Rochester, Minn., after his mother, Judy, was accepted into a nursing program affiliated with the renowned Mayo Clinic.

His father, Bob, found another farmer to lease the Iowa acreage and began trading commodities, a skill he honed hedging his crops each season.

Thierer, inspired by his parents’ aspirations, earned high marks in high school. He went on to the University of Minnesota School of Business, now known as the Curtis L. Carlson School of Management, with a single goal in mind.

“That was at a time (1978), when you were just hoping to get a job,” he said. “It was Get. A. Job.”

He had three of them in college, allowing him to graduate in four years with $11,000 in savings, the equivalent of more than $26,000 in today’s dollars.

“That was a lot of money back then,” he said. “But that was how farmers do it. … There was just this whole work ethic and savings mentality that was ingrained in me by my parents very early on.”

In June 1982, armed with a degree in finance, Thierer received job offers from five large, well-respected firms: Cargill, U.S. Steel, General Electric, First Bank (now part of Wells Fargo) and IBM.

After some consternation, Thierer opted to take a job with IBM in Rochester because it was known as a good, solid company — and he could live rent-free at home with his parents.

DNA to lead

Back at home, he flourished. By the end of 1982, IBM tapped him to join a newly formed office in Boca Raton, Fla., where IBM had just launched the brand’s first personal computer, what became known as the IBM PC.

Within 18 months, he was promoted to purchasing manager, overseeing 18 people, many older than him. At 24, he became the unit’s youngest front-line manager, a promotion he later called his “first big break.”

“I worked my buns off but was having a ball,” he said.

Determined to stay ahead in the competitive IBM outpost, Thierer enrolled in an MBA program at Nova Southeastern University in Fort Lauderdale, Fla., attending classes nights and weekends. He graduated with high honors and met his future wife, Nasrin, then

an electrical engineer for Motorola.

They married in 1987 and plan to celebrate their 25th anniversary on 12/12/12. They’ll renew their vows in Florida, where they’ve owned vacation property on the Gulf Coast for 20 years.

Both of their careers eventually brought them back to Chicago, and it was there, Nasrin Thierer said, where Mark’s already promising career really took off.

“When he came here, to Chicago, he really put his head down and took in every ounce of everything coming his way,” she said. “He really dove in and educated himself.”

Thierer landed on a team that sold IBM products to Chicago’s growing health care industry, including giant pharmaceutical firms Baxter International and Abbott Laboratories. In 1993, IBM started making overtures to bring Thierer to its headquarters outside New York City.

“I didn’t want to leave,” Thierer said. “Our life was in Chicago.”

So he quit.

Leveraging the contacts he made at Baxter, Thierer snagged a vice president of sales position at Caremark International, the newly independent pharmacy benefit manager Baxter had just spun off.

With his background in sales and wide network in health care, Thierer rose quickly. He gained a reputation as an extremely focused, team-oriented leader who consistently deflected success to those who worked for him.

Kraemer, who has kept tabs on Thierer throughout his career, said: “People don’t like working for this guy; they love working for this guy.”

But after 10 years at Caremark, “I saw myself moving into more of a leadership role, and the then-CEO saw it another way,” Thierer said. “It was a disappointment, for sure, but it was best that we parted ways.”

He joined medical records company Allscripts Inc., where he was president of a division called Physicians Interactive. Two years into his tenure, in 2005, he was asked to join the board of SXC. After a few board meetings, he said, he was asked to step into the president and chief operating officer roles.

Once he found his replacement at Allscripts, he took the reins at SXC in September 2006.

“This was a clear path to run a public company, and that’s exactly what I wanted,” Thierer said. “(Ever) since I was small, my parents would tell me all the time that I was a natural-born leader. And now I felt like I had all the tools. I felt like I had the DNA to do it. This was my opportunity to play my full hand.”

He is intent on making the most of it.

Strategic thinker

Thierer’s friends and business colleagues describe him as a “big-picture” thinker with an intense focus who is most often two steps ahead of everyone.

So it surprised few when Thierer’s first big bet at SXC paid off, though the move to enter the pharmacy benefit management business, a service-oriented field heavy on relationship-building, represented a stark departure for a tech company.

But it suited Thierer’s strengths as a “broad, strategic thinker who is long-suited in his interpersonal skills,” said Dave Carlquist, the top IBM executive in Chicago who has known Thierer for the better part of three decades. “Mark is very, very focused on client relationships and understanding the needs of his clients.”

After SXC integrated its first major acquisition, Thierer continued the strategy of snapping up customers, the small to midsize PBMs that play in the so-called middle market. That segment includes employers with 1,000 to 20,000 workers and health plans that cover fewer than 250,000 people.

The big splash came this summer, when the company acquired Catalyst Health Solutions Corp. for $4.4 billion. After the deal closed in July, SXC changed its name to Catamaran and said it expected to rake in more than $13 billion in 2013.

With the move, Catamaran became one of the largest companies in Chicago by revenue, providing services to an estimated 25 million people.

That sizable chunk of market share provides it with the scale it needs to sell its services to large employers and health plans, the largest of which can spend more than $300 million each year on prescription drugs for its employees.

Thierer said he is confident some of those big contracts will break to Catamaran. If not this year, in 2013.

Moreover, buying Catalyst also eliminated its major competition in industry consolidation. In turn, valuations of other midmarket PBMs should come down, making them more attractive takeover targets for Catamaran.

Thierer is quick to point out that there are $25 billion worth of potential targets in the field and insists that the buying spree is not over. Today, Catamaran has a 9 percent market share. Thierer wants to be at 15 percent within five years.

“We’re not even to midfield yet,” he says. “We’re going to guns. We’re going to be aggressive to grow the business.”

While statements like those have turned some heads within the industry, it’s not just bravado.

“What I’ve always liked about Mark is, what he says he’ll do, he does,” said Greg Wasson, chief executive of Walgreen Co., which has a long-standing business relationship with Catamaran. “As far as business is concerned, he plays to win; he’s intense.”

Wasson has known Thierer for about 10 years; they’re also neighbors. He said that although Thierer is a deft negotiator, he’s more of a business partner than an adversary.

Even among the growing cadre of Wall Street analysts who follow the firm, it’s hard to find any who question the company’s performance or strategy under Thierer. Of 25 analysts who cover Catamaran, 19 rate the company as a buy, according to Thomson Reuters/First Call. None rates it to underperform.

That’s exactly what the company had in mind when it embarked on a rebranding campaign, naming itself after a dual-hulled sailing vessel.

“Catamarans revolutionized the old sailing model and are twice as fast as the old, traditional models,” Thierer said. “In many respects, catamarans left the old models behind. That sounds like exactly who we are. We are hard to beat.”

And Thierer does not like to lose, even in a low-stakes bet on a golf course.

“It might be a $2 Nassau, but Mark’s going to be darn sure that he takes your $2 and is not the one paying you $2,” said IBM’s Carlquist, Thierer’s longtime golfing buddy. “Mark is steady and he’s focused. He’s the kind of guy that walks up to a knee-knocker 4-foot putt and knocks it in. Every time.”

[email protected]

Twitter @peterfrost

Mark Thierer

Chairman and CEO, Catamaran Corp.

Wife Nasrin, a former Motorola engineer, is founder and CEO of Revenew, a marketing portal that connects manufacturers and retailers. Daughter Stephanie, 22, lives in the Lincoln Park neighborhood and works for United HealthCare; son Jonathan, 19, studies opera at the Manhattan School of Music in New York.

Red wine, salmon, Florida’s Gulf Coast

Traveling, golf, collecting stickers, “Amazing Thierer Sticker Cards.” Keeps sticker stash in boxes in his den. Nasrin says she always knows he’s making a card when he disappears into his den and starts giggling.

Minnesota Vikings, opera, classical music

Civic involvement:

Serves on the boards of the Lyric Opera of Chicago, The Executives’ Club of Chicago, and the Museum of Science and Industry. Volunteers for the American Cancer Society’s CEOs Against Cancer and Habitat for Humanity and serves as an adviser for the Jeffrey Pride Foundation for Pediatric Cancer Research.

“I count my blessings all the time. This has become so much more than I ever envisioned; it candidly has exceeded my wildest expectations. I’m very emphatic with our people that this is a once-in-a-lifetime ride, and to take advantage of it, because this is a very special thing we’ve got going on.”

More in Business

Transportation | Pedestrian safety measures still lacking at many rail crossings — sometimes with tragic results

Health | New center for organ donors at Rush is first of its kind in Illinois

Business | Board of Elections objects to election workers’ union petition, saying union membership constitutes prohibited ‘political activity’

Daily Southtown | Palos 90-year-olds turn birthday greetings into fundraiser

Trending nationally.

• TRACKING MAP: Will potential Hurricane Helene hit Florida?
• 10th Rodanthe beach house since 2020 collapses into Atlantic as debris from homes piles up
• Not a scam: VA texting veterans to encourage them to apply for earned benefits
• Sean Combs is rooming with Sam Bankman-Fried at MDC Brooklyn
• Religious freedom, LGBTQ rights collide in lawsuit over Colorado’s universal preschool program

• Today's news
• Reviews and deals
• Climate change
• 2024 election
• Newsletters
• Fall allergies
• Health news
• Mental health
• Sexual health
• Family health
• So mini ways
• Unapologetically
• Buying guides

Entertainment

• How to Watch
• My Portfolio
• Latest News
• Stock Market
• The Morning Brief
• Biden Economy
• Stocks: Most Actives
• Stocks: Gainers
• Stocks: Losers
• Trending Tickers
• World Indices
• US Treasury Bonds Rates
• Top Mutual Funds
• Options: Highest Open Interest
• Options: Highest Implied Volatility
• Basic Materials
• Communication Services
• Consumer Cyclical
• Consumer Defensive
• Financial Services
• Industrials
• Real Estate
• Stock Comparison
• Advanced Chart
• Currency Converter
• Credit Cards
• Balance Transfer Cards
• Cash-back Cards
• Rewards Cards
• Travel Cards
• Credit Card Offers
• Best Free Checking
• Student Loans
• Personal Loans
• Car insurance
• Mortgage Refinancing
• Mortgage Calculator
• Editor's Picks
• Investing Insights
• Trending Stocks
• Morning Brief
• Opening Bid
• Fantasy football
• Pro Pick 'Em
• College Pick 'Em
• Fantasy baseball
• Fantasy hockey
• Fantasy basketball
• Download the app
• Daily fantasy
• Scores and schedules
• GameChannel
• World Baseball Classic
• Premier League
• CONCACAF League
• Champions League
• Motorsports
• Horse racing

New on Yahoo

• Privacy Dashboard

Yahoo Finance

Catamaran corporation (sxc.to), related tickers.